Our Mission

To accelerate breakthroughs, the Damon Runyon Cancer Research Foundation provides today’s best young scientists with funding to pursue innovative cancer research. Since its founding in 1946, Damon Runyon has invested nearly $355 million and funded nearly 3,700 young scientists.

Yung Lie

yung S. lie, phd, named Damon Runyon's next leader

Yung S. Lie, PhD, was appointed the incoming President and Chief Executive Officer of the Damon Runyon Cancer Research Foundation. Dr. Lie succeeds Lorraine W. Egan, who will step down in December. Read about Dr. Lie, a former Damon Runyon fellow, as she leads our efforts to end cancer.

Cooperman

Runyon Up at Salesforce Tower

Step up for cancer research on Sunday, October 21, 2018! Thanks to the generosity of Boston Properties, Salesforce and our Presenting Sponsor, Equinix, the Damon Runyon Cancer Research Foundation will host the first charitable stair climb to be held at the new 61-story Salesforce Tower – the tallest building in San Francisco. Learn more and register today at runyonup.org!

 

getting treatment results more rapidly

One of the hardest things for cancer patients is waiting to find out if a treatment worked. Often it takes months to complete a treatment and get the results--only to find out that the cancer did not respond. Read more about how Damon Runyon scientists have developed blood tests, called liquid biopsies, to speed up this process.